Published in Arch Gen Psychiatry on January 01, 1980
INTEGRATIVE BORDERLINE ADOLESCENT FAMILY THERAPY: MEETING THE CHALLENGES OF TREATING ADOLESCENTS WITH BORDERLINE PERSONALITY DISORDER. Psychotherapy (Chic) (2003) 0.81
The relationship between childhood adversity and dysphoric inner states among borderline patients followed prospectively for 10 years. J Pers Disord (2013) 0.78
The Collaborative Longitudinal Personality Disorders Study: reliability of axis I and II diagnoses. J Pers Disord (2000) 4.99
Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res (1997) 3.54
Residual symptoms after partial remission: an important outcome in depression. Psychol Med (1995) 3.23
The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand (2000) 3.06
Treatment utilization by patients with personality disorders. Am J Psychiatry (2001) 3.03
The diagnostic Interview for Personality Disorders: interrater and test-retest reliability. Compr Psychiatry (1988) 3.01
The process of metastasisation for breast cancer. Eur J Cancer (2003) 2.30
Distinguishing borderline personality disorder from bipolar disorder: differential diagnosis and implications. Am J Psychiatry (1996) 2.24
Clinical and economic choices in anaesthesia for day surgery: a prospective randomised controlled trial. Anaesthesia (2003) 2.08
Psychotherapy of schizophrenia: an empirical investigation of the relationship of process to outcome. Am J Psychiatry (1989) 2.06
Propofol and halothane versus sevoflurane in paediatric day-case surgery: induction and recovery characteristics. Br J Anaesth (2003) 1.78
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer (2002) 1.77
Male pelvic anatomy reconstructed from the visible human data set. J Urol (1998) 1.59
The pain of being borderline: dysphoric states specific to borderline personality disorder. Harv Rev Psychiatry (1999) 1.56
Diagnosing borderline patients with a semistructured interview. Arch Gen Psychiatry (1980) 1.55
Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res (1996) 1.47
Stressful life events as predictors of functioning: findings from the collaborative longitudinal personality disorders study. Acta Psychiatr Scand (2004) 1.44
Cognitive features of borderline personality disorder. Am J Psychiatry (1990) 1.43
The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Arch Gen Psychiatry (1990) 1.43
Laparoscopic oophorectomy in children. J Laparoendosc Surg (1996) 1.42
The diagnostic interview for borderline patients. Am J Psychiatry (1981) 1.39
Upper gastrointestinal disease in rheumatoid arthritis. Am J Dig Dis (1974) 1.38
A little cream and sugar: psychotherapy with a borderline patient. Am J Psychiatry (1998) 1.38
Co-occurrence of mood and personality disorders: a report from the Collaborative Longitudinal Personality Disorders Study (CLPS). Depress Anxiety (1999) 1.37
Oestrogen sulfotransferase: molecular cloning and sequencing of cDNA for the bovine placental enzyme. Aust J Biol Sci (1988) 1.32
Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophr Bull (1984) 1.30
Discriminating borderline personality disorder from other axis II disorders. Am J Psychiatry (1990) 1.29
Personality traits as prospective predictors of suicide attempts. Acta Psychiatr Scand (2009) 1.28
The 10-year course of physically self-destructive acts reported by borderline patients and axis II comparison subjects. Acta Psychiatr Scand (2008) 1.27
Internal consistency, intercriterion overlap and diagnostic efficiency of criteria sets for DSM-IV schizotypal, borderline, avoidant and obsessive-compulsive personality disorders. Acta Psychiatr Scand (2001) 1.23
Molecular mechanics calculations of the structures of polyamide nucleic acid DNA duplexes and triple helical hybrids. Proc Natl Acad Sci U S A (1993) 1.20
Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene (1992) 1.20
Childhood experiences of borderline patients. Compr Psychiatry (1989) 1.18
Discriminating features of borderline patients. Am J Psychiatry (1978) 1.18
The validity of DSM-III borderline personality disorder. A phenomenologic, family history, treatment response, and long-term follow-up study. Arch Gen Psychiatry (1983) 1.13
Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Eur J Surg Oncol (2005) 1.11
Changes in self-destructiveness of borderline patients in psychotherapy. A prospective follow-up. J Nerv Ment Dis (1995) 1.10
Food outlet visits, physical activity and body weight: variations by gender and race-ethnicity. Br J Sports Med (2008) 1.08
A cluster of Legionnaires' disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008-2009. Euro Surveill (2010) 1.07
Violence in the lives of adult borderline patients. J Nerv Ment Dis (1999) 1.07
Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components. Lab Invest (1997) 1.07
Clinical markers of serious illness in young infants: a multicentre follow-up study. J Paediatr Child Health (2000) 1.04
Survival from accidental strangulation from a scarf resulting in laryngeal rupture and carotid artery stenosis: the "Isadora Duncan syndrome". A case report and review of literature. Emerg Med J (2003) 0.99
Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults. Am J Med (1987) 0.99
Thoracoscopic management of empyema in children. J Laparoendosc Surg (1996) 0.98
The association of personality disorders with the prospective 7-year course of anxiety disorders. Psychol Med (2010) 0.98
Comparison of alternative models for personality disorders, II: 6-, 8- and 10-year follow-up. Psychol Med (2011) 0.97
Psychotherapy of schizophrenia. What happens to treatment dropouts. J Nerv Ment Dis (1984) 0.96
Special report: schizophrenia 1976. Schizophr Bull (1976) 0.94
Are we ready for NICE head injury guidelines in Scotland? Emerg Med J (2004) 0.94
Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Am J Hum Genet (1994) 0.94
Axis I phenomenology of borderline personality disorder. Compr Psychiatry (1989) 0.94
Avoidant personality disorder and social phobia: distinct enough to be separate disorders? Acta Psychiatr Scand (2005) 0.94
Consequences of the combined loss of BOK and BAK or BOK and BAX. Cell Death Dis (2013) 0.94
Improvement in borderline personality disorder in relationship to age. Acta Psychiatr Scand (2008) 0.93
Defining the therapeutic processes in psychiatric milieus. Psychiatry (1978) 0.92
Current overview of the borderline diagnosis. J Clin Psychiatry (1987) 0.91
An examination of the borderline diagnosis in children. Am J Psychiatry (1986) 0.91
The effect of anaesthetic agents on induction, recovery and patient preferences in adult day case surgery: a 7-day follow-up randomized controlled trial. Eur J Anaesthesiol (2008) 0.91
Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. Int J Cancer (1997) 0.90
Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat. Brain Res (2006) 0.90
A phase I study of irinotecan administered on a weekly schedule in pediatric patients. Pediatr Blood Cancer (2006) 0.90
Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas. Oncogene (1998) 0.89
Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Genes Chromosomes Cancer (1997) 0.89
No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms. Gynecol Oncol (1998) 0.88
Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophr Bull (1984) 0.88
Reaction time and prognosis in acute schizophrenia. J Nerv Ment Dis (1971) 0.87
Better than expected: improvements in borderline personality disorder in a 3-year prospective outcome study. Compr Psychiatry (1995) 0.87
A state-based immunization campaign: the New Mexico experience. J Sch Health (1997) 0.87
The cost of schizophrenia. Am J Psychiatry (1975) 0.86
The search for a schizotype. Crossing the border again. Arch Gen Psychiatry (1983) 0.86
Endocrine and exocrine pancreatic function in treated coeliac disease. Pancreas (1986) 0.86
Risk factors associated with the dissociative experiences of borderline patients. J Nerv Ment Dis (2000) 0.86
Perceived risk of bovine spongiform encephalopathy and dietary behavior. J Health Psychol (2003) 0.86
Increased expression of the NME1 gene is associated with metastasis in epithelial ovarian cancer. Int J Cancer (1995) 0.86
Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis. Ann Rheum Dis (2005) 0.86
Optimization of a Rayleigh-type equation for the detection of tritanomaly. Vision Res (1979) 0.86
Pharmacotherapy for patients with borderline personality disorder. Arch Gen Psychiatry (1986) 0.85
Borderline and schizophrenic patients: A comparative study. Am J Psychiatry (1975) 0.85
Reliability and validity of depressive personality disorder. Am J Psychiatry (1998) 0.84
Longitudinal diagnostic efficiency of DSM-IV criteria for obsessive-compulsive personality disorder: a 2-year prospective study. Acta Psychiatr Scand (2004) 0.84
Completed psychotherapies with borderline patients. Am J Psychother (1984) 0.84
Comparison of breast and rectal cancer patients' quality of life: results of a four year prospective field study. Eur J Cancer Care (Engl) (2003) 0.84
Behavioural toxicity of antidepressants with particular reference to moclobemide. Psychopharmacology (Berl) (1992) 0.84
Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations. Genes Chromosomes Cancer (1997) 0.84
A reevaluation of milieu therapy for nonchronic schizophrenic patients. Schizophr Bull (1980) 0.83
Transitional object use and borderline psychopathology. Am J Psychiatry (1986) 0.82
Detection of tuberous sclerosis in parents by magnetic resonance imaging. Neurology (1991) 0.82
Prophylaxis for venous thromboembolism in head and neck surgery: the practice of otolaryngologists. J Laryngol Otol (1997) 0.82
Cognitive and perceptual distortions in borderline personality disorder and schizotypal personality disorder in a vignette sample. Compr Psychiatry (1992) 0.82
Effects of bovine growth hormone (bGH) transgene expression or bGH treatment on reproductive functions in female mice. Biol Reprod (1995) 0.81
Pharmacotherapy of borderline outpatients. Compr Psychiatry (1988) 0.81
Personality disorders in cocaine dependence. Compr Psychiatry (1993) 0.81
The search for a schizotypal personality: historical origins and current status. Compr Psychiatry (1983) 0.80
Which anaesthetic agents are cost-effective in day surgery? Literature review, national survey of practice and randomised controlled trial. Health Technol Assess (2002) 0.80
A review of the depressive personality. Am J Psychiatry (1990) 0.79
Personality dimensions associated with depressive personality disorder. J Pers Disord (1998) 0.79
Relatedness of schizotypal to schizophrenic disorders: editors' introduction. Schizophr Bull (1985) 0.79
Family images of borderline adolescents. Psychiatry (1995) 0.79
The interface between borderline personality disorder and affective disorder. Am J Psychiatry (1985) 0.79